Carmen Evans
Family · Garden City, MINPI 1053097733
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 6.2% — the pattern of someone who eats at a lot of different presentations.
Across 82 payments — averaging $30.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$154
- Sanofi$142
- Novartis$141
- Neurocrine Biosciences, Inc.$139
- Takeda Pharmaceuticals U.S.A., Inc.$138
- Merck$132
- plus $2K from 29 others
What the payments were for
- Food & beverage$2,483100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $154 |
| Sanofi | 2 | $142 |
| Novartis | 12 | $141 |
| Neurocrine Biosciences, Inc. | 1 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $138 |
| Merck | 5 | $132 |
| Alkermes, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Axsome Therapeutics, Inc. | 1 | $107 |
| Johnson & Johnson | 5 | $106 |
| Beone Medicines USA, Inc. | 4 | $106 |
| Daiichi Sankyo Inc. | 5 | $104 |
| Pharmaessentia USA Corporation | 4 | $96 |
| Karyopharm Therapeutics Inc. | 3 | $87 |
| Legend Biotech USA Inc. | 3 | $80 |
| Genentech USA, Inc. | 3 | $73 |
| AstraZeneca(2 entities) | 3 | $70 |
| Bristol Myers Squibb | 2 | $64 |
| Sobi, Inc | 2 | $57 |
| Geron Corporation | 1 | $53 |
| Pfizer | 2 | $49 |
| Incyte Corporation | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Tersera Therapeutics LLC | 2 | $38 |
| Taiho Oncology, Inc. | 1 | $33 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Gilead | 1 | $23 |
| Cordis US CORP. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Deciphera Pharmaceuticals Inc. | 1 | $20 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| Beigene USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| Exelixis Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$499
- INGREZZA$139
- CERDELGA$126
- CEREZYME$126
- ABILIFY MAINTENA$121
- ABILIFY ASIMTUFII$121
- UZEDY$113
- Auvelity$107
How this compares
$2,483 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Other family in Garden City
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.